Expression of Concern on “Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial”

No Authors listed

[Not Applicable]

---

• Expression of concern

The Editor in Chief and the Publisher are issuing an expression of concern regarding the following article:

Gerli S, Mignosa M, Di Renzo GC. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci 2003; 7(6): 151-159–PMID: 15206484.

This Expression of Concern is issued following a whistleblower’s report regarding errors in the study protocol and results, as well as ethical concerns.

The authors have informed the journal that the original data are no longer available due to the 22 years that have elapsed since the article’s publication. In the absence of these data, we are issuing this Expression of Concern to alert readers that concerns have been raised about this article.

The Publisher apologizes for any inconvenience this may cause.

Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial